Does CANDESARTAN Cause Agranulocytosis? 23 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Agranulocytosis have been filed in association with CANDESARTAN. This represents 0.3% of all adverse event reports for CANDESARTAN.
23
Reports of Agranulocytosis with CANDESARTAN
0.3%
of all CANDESARTAN reports
1
Deaths
21
Hospitalizations
How Dangerous Is Agranulocytosis From CANDESARTAN?
Of the 23 reports, 1 (4.3%) resulted in death, 21 (91.3%) required hospitalization, and 5 (21.7%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANDESARTAN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does CANDESARTAN Cause?
Off label use (1,911)
Fatigue (1,468)
Dyspnoea (1,456)
Pain (1,455)
Drug ineffective (1,428)
Headache (1,371)
Nausea (1,282)
Dizziness (1,237)
Vomiting (1,202)
Diarrhoea (1,145)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which CANDESARTAN Alternatives Have Lower Agranulocytosis Risk?
CANDESARTAN vs CANDESARTAN CILEXETIL
CANDESARTAN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANDESARTAN vs CANGRELOR
CANDESARTAN vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN vs CANNABIDIOL